Shandong Xinhua Pharmaceutical Company Statistics

Total Valuation

Shandong Xinhua Pharmaceutical Company has a market cap or net worth of HKD 9.84 billion. The enterprise value is 10.64 billion.

Market Cap	9.84B
Enterprise Value	10.64B

Important Dates

The last earnings date was Thursday, October 24, 2024.

Earnings Date	Oct 24, 2024
Ex-Dividend Date	Sep 4, 2024

Share Statistics

Shandong Xinhua Pharmaceutical Company has 682.41 million shares outstanding. The number of shares has increased by 0.91% in one year.

Current Share Class	n/a
Shares Outstanding	682.41M
Shares Change (YoY)	+0.91%
Shares Change (QoQ)	-0.85%
Owned by Insiders (%)	0.53%
Owned by Institutions (%)	2.03%
Float	411.38M

Valuation Ratios

The trailing PE ratio is 8.18.

PE Ratio	8.18
Forward PE	n/a
PS Ratio	0.44
PB Ratio	0.74
P/TBV Ratio	n/a
P/FCF Ratio	21.47
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.52, with an EV/FCF ratio of 56.85.

EV / Earnings	21.42
EV / Sales	1.15
EV / EBITDA	9.52
EV / EBIT	20.16
EV / FCF	56.85

Financial Position

The company has a current ratio of 1.34, with a Debt / Equity ratio of 0.33.

Current Ratio	1.34
Quick Ratio	0.84
Debt / Equity	0.33
Debt / EBITDA	1.64
Debt / FCF	9.80
Interest Coverage	12.69

Financial Efficiency

Return on equity (ROE) is 9.42% and return on invested capital (ROIC) is 4.65%.

Return on Equity (ROE)	9.42%
Return on Assets (ROA)	3.56%
Return on Capital (ROIC)	4.65%
Revenue Per Employee	1.30M
Profits Per Employee	69,948
Employee Count	7,104
Asset Turnover	1.00
Inventory Turnover	5.66

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +2.79% in the last 52 weeks. The beta is -0.03, so Shandong Xinhua Pharmaceutical Company's price volatility has been lower than the market average.

Beta (5Y)	-0.03
52-Week Price Change	+2.79%
50-Day Moving Average	5.87
200-Day Moving Average	5.54
Relative Strength Index (RSI)	46.17
Average Volume (20 Days)	2,264,145

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Shandong Xinhua Pharmaceutical Company had revenue of HKD 9.23 billion and earned 496.91 million in profits. Earnings per share was 0.72.

Revenue	9.23B
Gross Profit	2.23B
Operating Income	528.06M
Pretax Income	530.69M
Net Income	496.91M
EBITDA	1.11B
EBIT	528.06M
Earnings Per Share (EPS)	0.72

Full Income Statement

Balance Sheet

The company has 1.28 billion in cash and 1.84 billion in debt, giving a net cash position of -552.49 million or -0.81 per share.

Cash & Cash Equivalents	1.28B
Total Debt	1.84B
Net Cash	-552.49M
Net Cash Per Share	-0.81
Equity (Book Value)	5.64B
Book Value Per Share	7.91
Working Capital	1.03B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 490.98 million and capital expenditures -303.74 million, giving a free cash flow of 187.24 million.

Operating Cash Flow	490.98M
Capital Expenditures	-303.74M
Free Cash Flow	187.24M
FCF Per Share	0.27

Full Cash Flow Statement

Margins

Gross margin is 24.15%, with operating and profit margins of 5.72% and 5.38%.

Gross Margin	24.15%
Operating Margin	5.72%
Pretax Margin	5.75%
Profit Margin	5.38%
EBITDA Margin	12.07%
EBIT Margin	5.72%
FCF Margin	2.03%

Dividends & Yields

This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 0.91%.

Dividend Per Share	0.05
Dividend Yield	0.91%
Dividend Growth (YoY)	37.70%
Years of Dividend Growth	1
Payout Ratio	49.97%
Buyback Yield	-0.91%
Shareholder Yield	-0.00%
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Stock Splits

The last stock split was on July 6, 2018. It was a forward split with a ratio of 1.3.

Last Split Date	Jul 6, 2018
Split Type	Forward
Split Ratio	1.3

Scores

Shandong Xinhua Pharmaceutical Company has an Altman Z-Score of 3.21.

Altman Z-Score	3.21
Piotroski F-Score	n/a